Stay updated on Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-29T23:55:04.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-22T17:52:56.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 6, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.7%
    Check dated 2025-04-08T09:27:58.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page has updated its status from 'Recruiting' to 'Active, not recruiting' and has changed the relevant date from '2024-10-15' to '2025-03-06'.
    Difference
    2%
    Check dated 2025-03-10T16:55:18.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T10:07:32.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T01:55:53.000Z thumbnail image

Stay in the know with updates to Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.